2Papsrella S.Hlgh-alert medication:shared accountability for risk identification and error prevenfion.J Emerg Nurs, 2010, 36(5):476- 489.
3Speck U, Scheller B, Rutsch W, et al. Local drug delivery-the early Berlin experience:single drug administration versus sustained2011, 7(6):7-22.
4He Er.Strengthening the management of high-alert medication in inpatient ward with soft Hard Environment Litigan(SHEL).Steait Pharm J, 2011, 23(9):239-240.
5Klepstad P, Kaasa S, Borchgrevink PC.Starting step Ⅲ opioids for moderate to severe pain in cancer patients dosetitration:a systematic review.Palliat Med, 2011, 25(5):424-430.
6Pedersen CA, Schneider PJ, Scheekelhoff DJ. ASHP national surveyof pharmacy practice in hospital settings: monitoring and patient education-2009.Am J Health Syst Pharm, 2010, 67(7):542-558.
10Garcia DA,Lopes RD,Hylek EM. New-onset atrial fibrillation and warfarin initiation:high risk periods and implications for new antithrombotic drugs[J].Thrombosis and Haemostasis,2010,(06):1099.
